European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...

According to Drugmaker Biogen Idec this Tuesday, it has received U.S. approval for an easier-to-use form of its multiple sclerosis injection Avonex. The Food and Drug Administration approved the ...

AVONEX PEN, the first intramuscular (IM) autoinjector approved for MS, incorporates a smaller needle and easier administration to help patients reduce anxiety about AVONEX self-injection. A new dose ...

Owen Mumford has released a new injection pen training video. Developed in collaboration with consultant pharmacists and nursing professionals, the video addresses critical steps when clinically ...

For patients suffering from Multiple Sclerosis (MS), a disease of the nervous system, treatment with long painful needles may soon be a thing of the past as shorter and thinner needle injections are ...

Avonex is a prescription drug that treats relapsing forms of multiple sclerosis (MS) in adults, such as relapsing-remitting MS, active secondary progressive MS, and clinically isolated syndrome.

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...

Procedures to introduce pen injections for patients suffering from Multiple Sclerosis (MS) should be concluded shortly, and will be distributed to patients once the previous formulation is exhausted, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Biogen Idec (Nasdaq: BIIB), a biotechnology company best ...

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...

WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...